USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Biotechnology Instruments Market Product (Lab Automation Instruments, Life Science Consumables, IVD Instruments, and Medical Lasers), and End-User (Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026

Covid-19

Global Biotechnology Instruments Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

According to the report published by Facts and Factors, global demand for the biotechnology instruments market was estimated at approximately USD 41,006.2 Million in 2020 and is expected to generate revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% between 2021 and 2026.

logoMarket Overview

Biomedical Instrumentation or Bioinstrumentation refers to the application of biomedical engineering that is focusing on the devices and mechanics, which are used in measuring, evaluating, and treating biological systems.

logoIndustry Growth Factor

The global market of biotechnology instruments is expected to grow at a significant growth rate during the forecast period. The high adoption of point-of-care diagnostic devices is a key growth factor that is driving the growth of the global biotechnology instruments market. Moreover, the huge increase in demand for biotechnology products for the production of personalized medicine is likely to propel the global market of biotechnology instruments in the upcoming years.

Furthermore, the continuous developments in research and development have improved the capabilities of point-of-care (POC) testing systems. The novel equipment presents an extensive menu of tests that is able used in numerous hospital settings. The novel POC devices let real-time transmission of test results to the electronic medical record of patients to get an effortless review from physicians. The systems are designed in a method, where they can effortlessly meet the terms with changes in laboratory regulations.

Moreover, the increasing occurrence of chronic disorders such as diabetes, cancer, and heart diseases, cardiovascular disorders, as well as infectious diseases like COVID-19, and others, is also anticipated to boost the global biotechnology instruments market escalation.  Besides, the immense increase in the use of 2D and 3D cell cultures in the area of discovery and manufacture of novel drug compounds is propelling the expansion of the global biotechnology instruments market. The growing research activities surrounding gene expression, mainly since the initiation of the Human Genome Project, have further advanced the global demand for microarrays for studying the genotype or gene clusters expression, boosting the global market of biotechnology instruments.

Biotechnology Instruments Market

logoSegmentation Analysis

The global biotechnology instruments market has been segmented into product and end-user. On the basis of product, the global biotechnology instruments market has been classified into lab automation instruments, life science consumables, IVD instruments, and medical lasers. In terms of the end-user industry, the global biotechnology instruments market has been bifurcated into government & academic institutes, pharmaceutical & biotechnology companies, hospitals & healthcare facilities, and others.

logoReport Scope

Report Attribute

Details

Market Size in 2020

USD 41,006.2 Million

Projected Market Size in 2026

USD 80,051.1 Million

CAGR Growth Rate

12.66% CAGR

Base Year

2020

Forecast Years

2021-2026

Key Market Players

Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, and others

Key Segment

By Product, By End-User, and By Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logo Regional Analysis

The global biotechnology instruments market has been classified into North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa. In terms of revenue, North America is accounted for the largest market share in the global biotechnology instruments market. The high growth in this regional market can be attributed to the growing demand, the preference for manual automation in the pharmaceuticals, biotechnology, and associated industries in the region, the affordability of biotechnology instruments, and the rising demand for highly developed instruments to ease and speed up the procedure. Also, the accessibility of government funding for research and development activities is likely to drive market development.

The region of Asia-Pacific is anticipated to become the fastest-growing market during the forecast period. This is due to the increase in investments in the biotechnology area and the fast-developing economy.

logo Competitive Players

The major market players covered in the global biotechnology instruments market include Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, Perkin Elmer Inc., Novanta  Inc., Siemens  Healthineers, QIAGEN, Waters Corporation, Tecan Group AG, Zimmer MedizinSysteme GmbH, and Thermo Fisher Scientific Inc., and among others.

logo Product Segment Analysis

  • Lab Automation Instruments
  • Life Science Consumables
  • IVD Instruments
  • Medical Lasers

logo End-User Segment Analysis

  • Government & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Healthcare Facilities
  • Others

logo Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • The Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East Africa

Covid-19

Biotechnology Instruments Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Agilent Technologies
  • Becton Dickinsonand Company
  • Abbott
  • Alcon Inc.
  • AngioDynamics
  • Bio-Rad Laboratories
  • BioMerieux SA
  • BioTek Instruments Inc.
  • Cynosure LLC
  • Candela Medical
  • Endress+Hauser (Analytik Jena GmbH)
  • Danaher Corporation
  • IIlumina Inc.
  • F. Hoffmann-La Roche Ltd.
  • IRIDEX
  • Merck KGaA
  • Lumenis
  • Perkin Elmer Inc.
  • Novanta  Inc.
  • Siemens  Healthineers
  • QIAGEN
  • Waters Corporation
  • Tecan Group AG
  • Zimmer MedizinSysteme GmbH
  • Thermo Fisher Scientific Inc.
     

Frequently Asked Questions

The high adoption of point-of-care diagnostic devices is a key growth factor that is driving the growth of the global biotechnology instruments market.
The global demand for the biotechnology instruments market was estimated at approximately USD 41,006.2 Million in 2020 and is expected to generate revenue of around USD 80,051.1 Million by the end of 2026, growing at a CAGR of around 12.66% between 2021 and 2026.
In terms of revenue, North America is accounted for the largest market share in the global biotechnology instruments market.
The major market players covered in the global biotechnology instruments market include Agilent Technologies, Becton Dickinson, and Company, Abbott, Alcon Inc., AngioDynamics, Bio-Rad Laboratories, BioMerieux SA, BioTek Instruments Inc., Cynosure LLC, Candela Medical, Endress+Hauser (Analytik Jena GmbH), Danaher Corporation, IIlumina Inc., F. Hoffmann-La Roche Ltd., IRIDEX, Merck KGaA, Lumenis, Perkin Elmer Inc., Novanta Inc., Siemens Healthineers, QIAGEN, Waters Corporation, Tecan Group AG, Zimmer MedizinSysteme GmbH, and Thermo Fisher Scientific Inc., among others.
why choose fnf
key questions answers

Related Reports

report img

Cell and Gene Therapy Consumables Market Report 2022 – 2028

[216+ Pages Report] According to Facts and Factors, the global cell and gene therapy consumables market was worth USD 6,294.10 million in 2021 and is estimated to grow to USD 17,427.85 million by 2028, with a compound annual growth rate (CAGR) of approximately 18.50% over the forecast period. The ...

Published Date : 16-Aug-2022 | | Category : | Pages : 216 | Format : Read more

Inquiry for Buying Request Sample
report img

Biosensors Market Report 2021 – 2026

[210+ Pages Report] As per the Facts and Factors market research report, the globalBiosensors market generated sales revenue of USD 21.96 Billion in 2020. Further, the Biosensors sales are expected to generate revenue of USD 34.088 Billion by the end of the year 2026, increasing at a CAGR of aroun...

Published Date : 23-Jul-2021 | | Category : | Pages : 210 | Format : Read more

Inquiry for Buying Request Sample